Novel 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206 and 8843 molecules and uses therefor

An isolated 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206 or 8843 nucleic acid molecule selected from the group consisting of:

• a) a nucleic acid molecule comprising a nucleotide sequence which is at least 60% identical to the nucleotide sequence of SEQ ID NO:1, 3, 4, 6, 7, 9, 10, 12, 13, 15, 16, 18, 53, 55, 61, 63, 67, 69, 78, 80, 88, 90, 100, 102, 113, 115, 122, 124, 129 or 131, or the nucleotide sequence of the DNA insert of the plasmid deposited with ATCC Accession Number PTA-3437 or PTA-3435;
• b) a nucleic acid molecule comprising a fragment of at least 15 nucleotides of the nucleotide sequence of SEQ ID NO:1, 3, 4, 6, 7, 9, 10, 12, 13, 15, 16, 18, 53, 55, 61, 63, 67, 69, 78, 80, 88, 90, 100, 102, 113, 115, 122, 124, 129 or 131, or the nucleotide sequence of the DNA insert of the plasmid deposited with ATCC Accession Number PTA-3437 or PTA-3435;
• c) a nucleic acid molecule which encodes a polypeptide comprising the amino acid sequence of SEQ ID NO:2, 5, 8, 11, 14, 17, 54, 62, 68, 79, 89, 101, 114, 123 or 130, or the amino acid sequence encoded by the cDNA insert of the plasmid deposited with ATCC Accession Number PTA-3437 or PTA-3435;
• d) a nucleic acid molecule which encodes a fragment of a polypeptide comprising the amino acid sequence of SEQ ID NO:2, 5, 8, 11, 14, 17, 54, 62, 68, 79, 89, 101, 114, 123 or 130, or the amino acid sequence encoded by the cDNA insert of the plasmid deposited with ATCC Accession Number PTA-3437 or PTA-3435, wherein the fragment comprises at least 15 contiguous amino acids of SEQ ID NO:2, 5, 8, 11, 14, 17, 54, 62, 68, 79, 89, 101, 114, 123 or 130, or the amino acid sequence encoded by the cDNA insert of the plasmid deposited with ATCC Accession Number PTA-3437 or PTA-3435;
• e) a nucleic acid molecule which encodes a naturally occurring allelic variant of a polypeptide comprising the amino acid sequence of SEQ ID NO:2, 5, 8, 11, 14, 17, 54, 62, 68, 79, 89, 101, 114, 123 or 130, or the amino acid sequence encoded by the cDNA insert of the plasmid deposited with ATCC Accession Number PTA-3437 or PTA-3435, wherein the nucleic acid molecule hybridizes to a nucleic acid molecule comprising SEQ ID NO:1, 3, 4, 6, 7, 9, 10, 12, 13, 15, 16, 18, 53, 55, 61, 63, 67, 69, 78, 80, 88, 90, 100, 102, 113, 115, 122, 124, 129 or 131, or a complement thereof, under stringent conditions;
• f) a nucleic acid molecule comprising the nucleotide sequence of SEQ ID NO:1, 3, 4, 6, 7, 9, 10, 12, 13, 15, 16, 18, 53, 55, 61, 63, 67, 69, 78, 80, 88, 90, 100, 102, 113, 115, 122, 124, 129 or 131, or the nucleotide sequence of the DNA insert of the plasmid deposited with ATCC Accession Number PTA-3437 or PTA-3435;
• and
• g) a nucleic acid molecule which encodes a polypeptide comprising the amino acid sequence of SEQ ID NO:2, 5, 8, 11, 14, 17, 54, 62, 68, 79, 89, 101, 114, 123 or 130, or the amino acid sequence encoded by the cDNA insert of the plasmid deposited with ATCC Accession Number PTA-3437 or PTA-3435.